This topic contains a solution. Click here to go to the answer

Author Question: Why are all costs really opportunity costs?[br][br][b][color=#FBB117]Question ... (Read 100 times)

clmills979

  • Hero Member
  • *****
  • Posts: 551
Why are all costs really opportunity costs?

Question 2

Discuss the three fundamental economic questions that all nations must address.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

momo1250

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

An opportunity cost is what must be given up in order to get something else. Although it is convenient to measure many costs in monetary terms, ultimately all costs (some of which cannot be easily measured in monetary terms) are opportunity costs because there is always something that must be given up in order to get something else.

Answer to Question 2

The three fundamental economic questions are the What, How, and For Whom questions which must be addressed by all societies. The What question pertains to what should the nation produce. What combination of goods would be best? How should that combination of goods be produced is the How question. We want to produce goods in the most efficient manner in order to maximize production. The For Whom question addresses for whom should these goods be produced. Who will get them?




clmills979

  • Member
  • Posts: 551
Reply 2 on: Jun 30, 2018
Thanks for the timely response, appreciate it


flexer1n1

  • Member
  • Posts: 373
Reply 3 on: Yesterday
Excellent

 

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

For a complete list of videos, visit our video library